Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR Receives Allowance for Key US Patent

Dec 12, 2022 at 4:27 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment